Therapeutic compounds
US12098148B2 · kind B2 · utility
0Cited by
3References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2019 |
| Grant date | Sep 24, 2024 |
| Priority date | — |
| Expiry date | Oct 7, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.